Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1076
Abivax
ABVX
$7.59B
| $191M | 0.01% |
1,432,185
-272,773
| -16% | -$30.9M |
2023 Q4
10 quarters
|
|
1077
Franklin Electric
FELE
$4.37B
| $191M | 0.01% |
1,778,777
-204,196
| -10% | -$20.5M |
2013 Q2
52 quarters
|
|
1078
Toll Brothers
TOL
$12.3B
| $190M | 0.01% |
1,156,108
-117,640
| -9% | -$16.7M |
2013 Q2
52 quarters
|
|
1079
Skyworks Solutions
SWKS
$11.4B
| $190M | 0.01% |
2,806,748
+64,698
| +2% | +$4.4M |
2013 Q2
52 quarters
|
|
1080
ORIX
IX
$39.8B
| $190M | 0.01% |
4,998,666
-8,549
| -0.2% | -$304K |
2013 Q2
52 quarters
|
|
1081
Fortis
FTS
$27.5B
| $189M | 0.01% |
3,303,825
+1,372,308
| +71% | +$77.4M |
2016 Q4
38 quarters
|
|
1082
DELISTED
Apogee Therapeutics
APGE
| $189M | 0.01% |
1,421,681
+826,649
| +139% | +$74.5M |
2023 Q3
11 quarters
|
|
1083
Credicorp
BAP
$30.3B
| $189M | 0.01% |
484,116
-15,929
| -3% | -$5.45M |
2013 Q2
52 quarters
|
|
1084
Columbia EM Core ex-China ETF
XCEM
$2.11B
| $188M | 0.01% |
3,556,704
+395,135
| +12% | +$19.3M |
2022 Q4
14 quarters
|
|
1085
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $187M | 0.01% |
2,276,111
-218,914
| -9% | -$18.3M |
2013 Q2
52 quarters
|
|
1086
TD Synnex
SNX
$21.7B
| $187M | 0.01% |
700,251
+65,153
| +10% | +$15.7M |
2013 Q2
52 quarters
|
|
1087
Alcoa
AA
$11.1B
| $187M | 0.01% |
3,588,651
-507,159
| -12% | -$34M |
2013 Q2
52 quarters
|
|
1088
Penumbra
PEN
$12.6B
| $187M | 0.01% |
591,824
+190,468
| +47% | +$61.7M |
2015 Q3
43 quarters
|
|
1089
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$6.28B
| $185M | 0.01% |
2,871,608
+300,366
| +12% | +$17.2M |
2013 Q2
52 quarters
|
|
1090
Onto Innovation
ONTO
$13.6B
| $185M | 0.01% |
488,517
+52,492
| +12% | +$14.9M |
2013 Q4
50 quarters
|
|
1091
iShares MSCI USA Value Factor ETF
VLUE
$9.33B
| $185M | 0.01% |
924,975
-2,109
| -0.2% | -$378K |
2013 Q4
50 quarters
|
|
1092
lululemon athletica
LULU
$10.9B
| $185M | 0.01% |
1,618,224
-209,276
| -11% | -$28M |
2013 Q2
52 quarters
|
|
1093
Leidos
LDOS
$15.3B
| $185M | 0.01% |
1,792,747
+259,694
| +17% | +$34.5M |
2013 Q2
52 quarters
|
|
1094
Schwab Fundamental US Large Company Index ETF
FNDX
$27.9B
| $184M | 0.01% |
5,908,781
+472,446
| +9% | +$14.3M |
2015 Q1
45 quarters
|
|
1095
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.58B
| $183M | 0.01% |
3,904,106
+141,682
| +4% | +$6.64M |
2019 Q4
26 quarters
|
|
1096
Invesco S&P 500 Pure Value ETF
RPV
$1.66B
| $182M | 0.01% |
1,602,489
-169,542
| -10% | -$18.9M |
2013 Q2
52 quarters
|
|
1097
iShares MSCI Germany ETF
EWG
$1.43B
| $182M | 0.01% |
4,408,124
+2,043,913
| +86% | +$86M |
2013 Q2
52 quarters
|
|
1098
iShares ESG Optimized MSCI USA ETF
SUSA
$4.13B
| $182M | 0.01% |
1,180,021
+180,777
| +18% | +$26.7M |
2013 Q2
52 quarters
|
|
1099
Vanguard Communication Services ETF
VOX
$6.1B
| $182M | 0.01% |
989,123
-65,634
| -6% | -$12.6M |
2013 Q2
52 quarters
|
|
1100
iShares Future AI & Tech ETF
ARTY
$4.18B
| $182M | 0.01% |
2,385,990
+85,943
| +4% | +$5.7M |
2020 Q4
22 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.